Treatment with the highest dose of investigational injectable amycretin -- a unimolecular GLP-1 and amylin receptor agonist -- yielded a 22% weight loss after 36 weeks in a phase Ib/IIa trial, said ...
Medpage Today on MSN6d
No Clear Winner in SGLT2 Showdown for Cardiovascular Disease"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...
Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...
The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential new use, to reduce the risk of renal failure and cardiovascular death in people with chronic ...
We've tested and compared the top Samsung tablets on the market, and our top pick is the Samsung Galaxy Tab S10 Ultra, thanks to its large size, ultra-responsive S Pen, Galaxy AI capabilities ...
All your sorting types must be within a 15-character limit. Any characters above that will be cut off (TAB reserves 1 character to ensure each player is in a unique team). To get the most out of it, ...
AltTab brings the power of Windows alt-tab to macOS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback